Thermo Fisher Scientific Inc/ US8835561023 /
| 2024-05-16 10:10:00 PM | Chg. -1.87 | Volume | Bid2:29:50 PM | Ask2:29:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 597.15USD | -0.31% | 1.41 mill. Turnover: 335.68 mill. |
568.58Bid Size: 100 | 601.99Ask Size: 200 | 227.94 bill.USD | 0.23% | 38.48 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 15.52 USD | -12.56% |
| EPS Diluted: | 15.45 USD | -12.37% |
| Revenues per Share: | 112.39 USD | -3.55% |
| Book Value per Share: | 122.53 USD | 7.26% |
| Cash Flow per Share: | 22.04 USD | -7.18% |
| Dividend per Share: | 1.40 USD | 16.67% |
| Total | in mill. | |
| Revenues: | 42,857.00 USD | -4.58% |
| Net Income: | 5,995.00 USD | -13.74% |
| Operating Cash Flow: | 8,406.00 USD | - |
| Cash and Cash Equivalents: | 8,077.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 38.48 | 34.20 |
| P/S Ratio: | 5.31 | 4.72 |
| P/BV ratio: | 4.87 | 4.33 |
| P/CF Ratio: | 27.09 | 24.08 |
| PEG: | -3.06 | -2.72 |
| Earnings Yield: | 2.60% | 2.92% |
| Dividend Yield: | 0.23% | 0.26% |
| Market Capitalization | ||
| Market Capitalization: | 227.94 bill. USD | 202.4 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 381.31 mill. | |
Profitability
| Gross Profit Margin: | - |
| EBIT Margin: | 16.00% |
| Net Profit Margin: | 13.99% |
| Return on Equity: | 12.83% |
| Return on Assets: | 6.07% |
Financial Strength
| Liquidity I / Cash Ratio: | 57.64% |
| Liquidity II / Quick Ratio: | 116.31% |
| Liquidity III / Current Ratio: | 175.49% |
| Debt / Equity Ratio: | 111.30% |
| Dynam. Debt / Equity Ratio: | 618.63% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
